Figure 1. Schematic of a photodynamic nanoplatform for cancer therapy.
nm) will not penetrate far beyond the tumor, even if non-tumor cells contain the drug; and PDT will not cause damage to cells that neither the light nor the drug reach. Thus, compared to chemotherapy and radiation therapy, PDT is quite benign. The question that now arises is whether we can extend this approach to the treatment of non-superficial tumors or to tumors that are diagnosed non-visually (with later confirmation by biopsy).
Some researchers have suggested the use of infrared active dyes in PDT, 2 as the activating infrared photons can penetrate deeper into tissue than visible light. An analogous approach involves pulsed infrared photons used in combination with twophoton-absorbing PDT drug molecules. 3 While this method also provides deeper photon penetration, it exacerbates the nonselectivity of the method as well: more non-tumorous tissue will be harmed.
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The new PDT paradigm addressed here consists of nanoplatforms, which are nanoparticles (NP) that combine PDT with tumor detection and tumor imaging (see Figure 1 ). These NP, when injected into the bloodstream, find the cancer cells and enter them using selective molecular targeting. At the same time, they enable external MRI or optical imaging of the tumor. This allows one to aim a laser, via an optical fiber, at the tumor.
The NP PDT approach has been demonstrated 4 on rats bearing the deadliest human brain cancer, 9L Glioma. Control mice with 5mm brain tumors survive only one week; those treated with existing therapeutic approaches live less than two weeks. But 60% of NP PDT treated rats were cured of their brain tumors. The procedure involved only 5min illumination by a 1W helium-neon laser, using a fiber inserted through the skull with a hemispherical diffuser.
With the same tumor, survival time for humans is only 4-6 months, and neither chemotherapy nor radiation therapy are effective. More details on these nano-drugs, including their synthesis, composition, and toxicology, are given in a paper by Yong-Eun Koo et al. 5 The latest additions to these "photonic drugs" are PDT NPs that utilize two-photon excitation. 6 Using an experimental twophoton PDT dye (embedded in the NP) and a pulsed Ti:sapphire laser, we demonstrated the effectiveness of this technique on live breast-cancer cells (see Figures 2 and 3) .
Once more-efficient two-photon dye-based NP are perfected, a second generation of such nano-drugs should work not only for highly-transparent brain tumors but also for other tumors in areas of the body with lower optical transparency. 
